Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.
about
Identification of lipopolysaccharide-binding peptide regions within HMGB1 and their effects on subclinical endotoxemia in a mouse modelLipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranesBovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cellsSafety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent.Biophysical analysis of the interaction of the serum protein human β2GPI with bacterial lipopolysaccharide.Extraordinarily potent proinflammatory properties of lactoferrin-containing immunocomplexes against human monocytes and macrophages.The role of antimicrobial peptides in animal defenses.Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptideLactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex.Lactoferrin as a natural immune modulatorInteraction of pulmonary surfactant protein C with CD14 and lipopolysaccharideReceptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Lactoferrin and oral diseases: current status and perspective in periodontitis.Bovine Lactoferrin-Induced CCL1 Expression Involves Distinct Receptors in Monocyte-Derived Dendritic Cells and Their Monocyte Precursors.Usefulness of ELISA Methods for Assessing LPS Interactions with Proteins and Peptides.Anti-infectious and anti-inflammatory effects of peptide fragments sequentially derived from the antimicrobial peptide centrocin 1 isolated from the green sea urchin, Strongylocentrotus droebachiensis.The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections.Endotoxin{middle dot}albumin complexes transfer endotoxin monomers to MD-2 resulting in activation of TLR4Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes.Reciprocal interactions between lactoferrin and bacterial endotoxins and their role in the regulation of the immune responseLactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections.Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesisLipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS.Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis.Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helixLactoferrin in a Context of Inflammation-Induced Pathology.Establishment of a mouse model of lipopolysaccharide-induced neutrophilic nasal polyps.Recombinant human lactoferrin modulates human PBMC derived macrophage responses to BCG and LPS.Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice.Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and FutureLactoferrin: A Critical Player in Neonatal Host Defense
P2860
Q24306294-974851F4-F484-4421-B598-4A6E11C45C35Q24548769-3FD20681-2755-4C93-B9B5-CC7745186557Q28742177-CB0ECBBF-9A7D-4552-881F-F3CC1B41D8A6Q30397259-99653402-9472-4879-8189-2C84E7E4755EQ30996943-7A00308E-6C64-472D-8544-CA9044C8A452Q33729006-332674A6-74C2-4341-AB57-20956EB9329AQ33835332-4B74B7EE-F5A7-4DC9-89CA-E91AC971604FQ33988529-A8AD651A-A7E4-4B38-9632-DB4EAB61F65DQ34000667-724E34A4-7FDB-4793-BB83-4EE9B432E999Q34001784-86C6B033-B9E4-4254-AA8C-8B77A12EDAD5Q34005092-22413EBD-1C5F-42C6-9978-2698F3A1FEA2Q34043199-B23D149A-963E-4BC5-B05B-FE742C6092B3Q34527170-8AC32A76-AA80-4CD2-89FE-10F8C986665FQ35176262-9E6BA967-7C2D-4E0E-A7E2-BFD402593B59Q35857629-0D7C4A8A-D7FC-4828-B273-83947A052B99Q35875492-C0708E45-878D-4915-8EC6-DCB7BEC19877Q36036386-7C5DBAAD-C1B9-4415-9A4D-C9D7FB64DFC8Q36578817-CD5F9B81-746A-468E-8F18-44119B413D36Q36699496-A1776562-72AF-410B-826F-400BF0D184FCQ36796331-71E7F0F3-0106-4238-B9AB-A86191D9C52CQ36906599-29DD6D66-1B10-412D-B02D-36297C767214Q37954267-18CC2A18-E25A-46DB-9065-CB7A632ED722Q39159902-C960940F-BF59-41C0-A85B-153B9FA1D566Q39346883-EEB80DFD-577E-438C-AA71-BB2C67AC9E35Q39510738-55A2547B-9D93-4D61-9649-D8C8FE6DCC05Q39671919-EC3A9805-6EEC-44FE-AAB3-C302E72FC1D2Q39723291-2925BCE3-D479-406D-A528-7F084B3F6177Q46256576-43BE9A96-C543-44AE-AA58-0562A016DF67Q47113002-9A4D23AD-11B3-41F6-B7A7-C23DE04FF5F4Q51407200-29B5446E-A199-413A-9F49-327D05F33ABCQ51703011-94E07052-6891-4341-A1D9-E738DDE62669Q57175340-E840EC55-0AB6-47BB-BE77-337A45720815Q58764142-193FB22B-6463-41F4-AE2C-C4E78201697F
P2860
Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Lactoferrin inhibits the endot ...... olysaccharide-binding protein.
@ast
Lactoferrin inhibits the endot ...... olysaccharide-binding protein.
@en
type
label
Lactoferrin inhibits the endot ...... olysaccharide-binding protein.
@ast
Lactoferrin inhibits the endot ...... olysaccharide-binding protein.
@en
prefLabel
Lactoferrin inhibits the endot ...... olysaccharide-binding protein.
@ast
Lactoferrin inhibits the endot ...... olysaccharide-binding protein.
@en
P2093
P2860
P1476
Lactoferrin inhibits the endot ...... polysaccharide-binding protein
@en
P2093
E Elass-Rochard
J Mazurier
P S Tobias
P2860
P304
P407
P577
1998-02-01T00:00:00Z